Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA3 | P07451 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA6 | P23280 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3796629 | 0.98 | CHRM2 (0.48) | CHRM2CYP1A2MAPK1DNM1CA12 | |
| SCHEMBL1492443 | 0.98 | CHRM2 (0.48) | CHRM2CYP1A2MAPK1DNM1CA12 | |
| SCHEMBL15556814 | 0.93 | CHRM2 (0.42) | CHRM2CYP1A2MAPK1NFKB1DNM1 | |
| SCHEMBL3459171 | 0.92 | CYP1A2 (0.37) | CHRM2CYP1A2MAPK1NFKB1CA12 | |
| SCHEMBL9460351 | 0.88 | CHRM2 (0.42) | CHRM2CYP1A2MAPK1DNM1CA12 | |
| SCHEMBL9640544 | 0.87 | CYP1A2 (0.37) | CHRM2CYP1A2MAPK1NFKB1CA12 | |
| SCHEMBL15015862 | 0.87 | CYP1A2 (0.43) | CYP1A2MAPK1DNM1CA12CA1 | |
| Diaminooctane SCHEMBL6859268 | 0.84 | DNM1 (0.44) | CHRM2CYP1A2MAPK1NFKB1DNM1 | |
| SCHEMBL10706034 | 0.84 | ALDH1A1 (0.42) | CYP1A2MAPK1DNM1CA12CA1 | |
| SCHEMBL22482652 | 0.83 | LCK (0.40) | CHRM2CYP1A2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107540565-B | Preparation of N, N- (di) alkylaminoalkyl (meth) acrylamides or the corresponding esters and quaternary ammonium salts thereof | 赢创运营有限公司 | 2022-10-21 | — | — | CN | disclosed |
| EP-2841537-A1 | USE OF ADDITIVES WITH DETERGENT ACTION FOR FURTHER INCREASING THE CETANE NUMBER OF FUEL OILS | BASF SE (DE) | 2015-03-04 | — | — | EP | disclosed |
| US-8674133-B2 | Method for continuously producing alkylamino(meth)acrylamides | EVONIK RÖHM GMBH (DE) | 2014-03-18 | — | — | US | disclosed |
| WO-2013160294-A1 | USE OF ADDITIVES WITH DETERGENT ACTION FOR FURTHER INCREASING THE CETANE NUMBER OF FUEL OILS | BASF SE (DE) | 2013-10-31 | — | — | WO | disclosed |
| US-20130276362-A1 | USE OF ADDITIVES WITH DETERGENT ACTION FOR FURTHER INCREASING THE CETANE NUMBER OF FUEL OILS | BASF SE (DE) | 2013-10-24 | — | — | US | disclosed |
| EP-2157215-B1 | POLYURETHANE ELASTIC FIBER | ASAHI KASEI FIBERS CORP (JP) | 2011-12-28 | — | — | EP | disclosed |
| US-20110313195-A1 | METHOD FOR CONTINUOUSLY PRODUCING ALKYLAMINO(METH)ACRYLAMIDES | EVONIK ROEHM GMBH (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20100184347-A1 | POLYURETHANE ELASTIC FIBERS | ASAHI KASEI FIBERS CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| US-7723543-B2 | Method for the continuous production of alkyl amino acryl amides | EVONIK ROEHM GMBH (DE) | 2010-05-25 | — | — | US | disclosed |
| EP-2157215-A1 | POLYURETHANE ELASTIC FIBER | Asahi Kasei Fibers Corporation (JP) | 2010-02-24 | — | — | EP | disclosed |
| US-7586004-B2 | Method for continuously producing alkylamino(meth)acrylamides | ROEHM GMBH & CO. KG (DE) | 2009-09-08 | — | — | US | disclosed |
| US-20090149674-A1 | METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL AMINO ACRYL AMIDES | ROEHM GMBH (DE) | 2009-06-11 | — | — | US | disclosed |
| US-20070149811-A1 | Method for continuously producing alkylamino(meth)acrylamides | ROEHM GMBH & CO. KG (DE) | 2007-06-28 | — | — | US | disclosed |
| EP-0870765-B1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARM CO LTD (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-5981557-A | HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0870765-A1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313195-A1 | METHOD FOR CONTINUOUSLY PRODUCING ALKYLAMINO(METH)ACRYLAMIDES | ACR, TET2, PAM | CHRM2 3059/4885CYP1A2 264/4885MAPK1 2644/4885 |
| US-20090149674-A1 | METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL AMINO ACRYL AMIDES | ACR, NAAA, AANAT | CHRM2 3125/4885CYP1A2 213/4885MAPK1 3127/4885 |
| US-20070149811-A1 | Method for continuously producing alkylamino(meth)acrylamides | ACR, MMAB, TET2 | CHRM2 2763/4885CYP1A2 255/4885MAPK1 2640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.